|
|
|
Volumn 52, Issue 1, 1997, Pages 16-21
|
|
Pharmacoeconomic aspects of lipid lowering therapy;Aspects pharmaco-economiques des traitements hypolipidemiants
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTILIPEMIC AGENT;
PRAVASTATIN;
SIMVASTATIN;
HYPOCHOLESTEROLEMIC AGENT;
COST EFFECTIVENESS ANALYSIS;
ECONOMIC ASPECT;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPERLIPIDEMIA;
SHORT SURVEY;
ARTICLE;
COST BENEFIT ANALYSIS;
ECONOMICS;
PHARMACOECONOMICS;
SOCIOECONOMICS;
STATISTICAL MODEL;
ANTICHOLESTEREMIC AGENTS;
COST-BENEFIT ANALYSIS;
ECONOMICS, PHARMACEUTICAL;
HUMANS;
HYPERCHOLESTEROLEMIA;
MODELS, ECONOMIC;
PRAVASTATIN;
VALUE OF LIFE;
|
|
EID: 0030638798
PISSN: 00353663
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (1)
|
|
References (25)
|
